Registry-listed formulations

Rencofilstat · chembl:CHEMBL4297487

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

3 source entries across 1 studies. This list may not include all unresolved or historical entries.

  • rencofilstat, 75 mgRegistry intervention

    Linked study entry; product equivalence not established

    View study and source
  • rencofilstat, 150mgRegistry intervention

    Linked study entry; product equivalence not established

    View study and source
  • rencofilstat, 225 mgRegistry intervention

    Linked study entry; product equivalence not established

    View study and source

Success Metrics

Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Phase 2
2
100%

Phase Distribution

0

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution2 total trials
Phase 2Efficacy & side effects
2(100.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

2

all time

Status Distribution
Completed(1)
Other(1)

Detailed Status

Completed1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
2
Active
0
Success Rate
N/A
Most Advanced
Phase 2

Trials by Phase

Phase 22 (100.0%)

Trials by Status

completed150%
unknown150%

Recent Activity

0 active trials
Showing 2 of 2
completedphase_2

A Study to Evaluate the Safety and Efficacy of Rencofilstat in Adult Subjects With NASH F3

NCT05461105
unknownphase_2

A Study to Evaluate the Efficacy and Safety of Rencofilstat in Subjects With NASH and Advanced Liver Fibrosis

NCT05402371

Clinical Trials (2)

Showing 2 of 2 trials
NCT05461105Phase 2

A Study to Evaluate the Safety and Efficacy of Rencofilstat in Adult Subjects With NASH F3

Completed
NCT05402371Phase 2

A Study to Evaluate the Efficacy and Safety of Rencofilstat in Subjects With NASH and Advanced Liver Fibrosis

Unknown

All 2 trials loaded

Drug Details

Intervention Type
Drug
Molecule Type
Small molecule
Total Trials
2

External References

ChEMBL
CHEMBL4297487

Names & Codes

Research Codes

Cpi-431Cpi-431-32Crv-431